Woolworths-backed telehealth start-up Eucalyptus has made around $200 million in the past 18 months selling weight-loss services and drugs such as Wegovy, and plans to revive its mothballed men’s longevity service in Britain.
Eucalyptus has become the largest online weight-loss medication company in the country since it was founded in 2019. Investors including Blackbird Ventures, Woolworths’ venture capital arm and Mary Meeker’s Bond Capital have poured in about $150 million to value it at $560 million.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。